Bevacizumab and intraocular tumors: an intriguing paradox

PURPOSE: Bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor-A (VEGF-A), was originally developed as an anti-tumor treatment. In ocular oncology, it is being used to treat macular edema due to radiation retinopathy, but it may also be useful for the treatment of primar...

Descripción completa

Detalles Bibliográficos
Autores principales: el Filali, Mariam, Ly, Long V., Luyten, Gregorius P.M., Versluis, Mieke, Grossniklaus, Hans E., van der Velden, Pieter A., Jager, Martine J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472924/
https://www.ncbi.nlm.nih.gov/pubmed/23077404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472924/
https://www.ncbi.nlm.nih.gov/pubmed/23077404

Ejemplares similares